Collaborative Fund Advisors LLC Takes Position in Colgate-Palmolive Company $CL

Collaborative Fund Advisors LLC acquired a new position in Colgate-Palmolive Company (NYSE:CL) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 6,328 shares of the company’s stock, valued at approximately $539,000.

Several other large investors have also bought and sold shares of the company. Kemnay Advisory Services Inc. acquired a new stake in Colgate-Palmolive in the 4th quarter valued at about $25,000. CBIZ Investment Advisory Services LLC grew its stake in shares of Colgate-Palmolive by 86.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after purchasing an additional 150 shares during the last quarter. TD Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 61.4% in the 4th quarter. TD Capital Management LLC now owns 326 shares of the company’s stock worth $26,000 after purchasing an additional 124 shares in the last quarter. Triumph Capital Management raised its holdings in shares of Colgate-Palmolive by 62.9% in the 4th quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after purchasing an additional 127 shares in the last quarter. Finally, Jessup Wealth Management Inc acquired a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $26,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.0%

Colgate-Palmolive stock opened at $95.17 on Monday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02. The firm has a market capitalization of $76.15 billion, a price-to-earnings ratio of 37.03, a P/E/G ratio of 5.02 and a beta of 0.33. The company has a 50 day moving average price of $89.07 and a 200 day moving average price of $87.67.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. During the same period last year, the company posted $0.91 earnings per share. The firm’s quarterly revenue was up 8.4% compared to the same quarter last year. Research analysts forecast that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a dividend of $0.53 per share. The ex-dividend date is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 82.49%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CL. Piper Sandler decreased their price target on shares of Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. Wall Street Zen downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Sunday, March 29th. Bank of America reduced their price objective on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research note on Friday, April 10th. Sanford C. Bernstein began coverage on Colgate-Palmolive in a report on Thursday, June 11th. They issued a “market perform” rating and a $96.00 target price on the stock. Finally, Rothschild & Co Redburn set a $100.00 price target on Colgate-Palmolive and gave the stock a “buy” rating in a research note on Tuesday, April 21st. Twelve research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.